CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Clermont-Ferrand

About this trial

Acute ischemic stroke due to large vessel occlusion is responsible of cerebral blood flow impairment with a progressive and extensive ischemic process. Cerebral collateral circulation may preserve an ischemic penumbra that could recover providing timely reperfusion of the occluded vessel. Mechanical thrombectomy is the standard of care for anterior circulation large vessel reperfusion. Strategy to promote cerebral blood flow in collateral circulation before reperfusion is scarce and rely mainly on blood pressure maintenance. Carbon dioxide is a potent cerebral vasodilator that could enhance collateral circulation blood flow and cerebral protection before reperfusion. General anesthesia with endotracheal mechanical ventilation could be used for thrombectomy and give the opportunity to modulate and control carbon dioxide tension in the blood. This study will test the effect of moderate hypercapnia on penumbral collateral circulation before reperfusion during mechanical thrombectomy for anterior circulation acute ischemic stroke under general anesthesia.

Eligibility criteria

Qualifiers

None

Disqualifiers

Active smoker

Chronic respiratory failure with ambulatory oxygen supplementation

Obesity with BMI>40Kg/ m2

Intubation before the procedure

Trial design

Treatments tested in this trial

  • HYPERCAPNIA
  • NORMOCAPNIA

Treatment groups

50 Participants
are divided into 2 treatment groups